Trial
NCT00088829
Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Georgetown University
Collaborators
National Cancer Institute (NCI)
Condition
Breast Cancer
Intervention
paclitaxel
Why stopped
Investigator left institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-07-11